Charting Biotech’s Next Moves
The niche market segment that’s been dominating the attention of active traders over the last several weeks? Biotechnology! So where is biotech likely headed from… Read More »Charting Biotech’s Next Moves
This Options Trade Could Net A Quick 300% Gain By Taking Advantage Of Financials’ Weakness
Today’s article outlines an options trade that could net a quick 300% gain by taking advantage of one of the weakest sectors in the market… Read More »This Options Trade Could Net A Quick 300% Gain By Taking Advantage Of Financials’ Weakness
Will The Coronavirus Be Different For This Perennial Disease Outbreak Loser?
As has been the case with many small-cap biotech stocks amid the coronavirus pandemic, traders have gotten excited in recent weeks about the stock examined… Read More »Will The Coronavirus Be Different For This Perennial Disease Outbreak Loser?
These 25 Struggling Small-Company Stocks Could Surge, Especially If Buyers Swoop In
Some of the best opportunities going forward may be among the worst-performing small-company stocks that have gone public over the last 11 years, advises the… Read More »These 25 Struggling Small-Company Stocks Could Surge, Especially If Buyers Swoop In
The Massive – And Mysterious – Rally Of The World’s Best-Performing Stock
What’s clear is that, having surged 2,819% in the past 12 months (and 351% so far this year in the face of a market meltdown),… Read More »The Massive – And Mysterious – Rally Of The World’s Best-Performing Stock
Top Biotech Stocks For May – Including A High-Risk/High-Reward Play
When it comes to the top biotech stocks to consider buying this month, as identified in today’s article, one has a virtual monopoly in its… Read More »Top Biotech Stocks For May – Including A High-Risk/High-Reward Play
A Better Way To Play The Earnings Game?
Given the ability of earnings reports to catapult stock prices higher in a short period of time, the authors of today’s article state “It’s no… Read More »A Better Way To Play The Earnings Game?
Remdesivir’s COVID-19 Success Could Create A Big “Piggyback” Opportunity For This Under-The-Radar Biotech
There is currently only one drug that has demonstrated the potential to be a safe and effective treatment for COVID-19 in clinical trials: Gilead Sciences’… Read More »Remdesivir’s COVID-19 Success Could Create A Big “Piggyback” Opportunity For This Under-The-Radar Biotech
Following The Insiders Towards Returns
Restrictions put in place to help reduce the spread of COVID-19 are beginning to be eased in the U.S. and many other countries. At the… Read More »Following The Insiders Towards Returns
The Right Stocks Right Now: 3 Penny Stocks With “Strong Buy” Ratings And “Massive Upside Potential”
“We’re not in a true bull market – not by a long shot – but the recent bear has pushed prices down and the current… Read More »The Right Stocks Right Now: 3 Penny Stocks With “Strong Buy” Ratings And “Massive Upside Potential”